KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 77 filers reported holding KALA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $16,000 | -99.6% | 13,155 | -99.2% | 0.01% | -99.6% |
| Q3 2021 | $4,527,000 | -49.9% | 1,727,751 | +1.3% | 3.67% | -40.7% |
| Q2 2021 | $9,036,000 | -6.2% | 1,704,849 | +19.2% | 6.19% | -1.1% |
| Q1 2021 | $9,638,000 | +24.4% | 1,430,021 | +25.2% | 6.26% | +29.7% |
| Q4 2020 | $7,745,000 | +33.8% | 1,142,360 | +48.0% | 4.83% | -11.5% |
| Q3 2020 | $5,788,000 | -11.2% | 771,790 | +24.4% | 5.46% | -20.7% |
| Q2 2020 | $6,519,000 | -59.6% | 620,289 | -66.2% | 6.88% | -61.0% |
| Q1 2020 | $16,141,000 | +194.9% | 1,836,313 | +23.8% | 17.64% | +234.2% |
| Q4 2019 | $5,474,000 | -3.0% | 1,483,343 | 0.0% | 5.28% | -17.0% |
| Q3 2019 | $5,644,000 | -41.2% | 1,483,343 | -1.4% | 6.36% | -41.6% |
| Q2 2019 | $9,597,000 | -22.7% | 1,504,272 | +0.2% | 10.90% | -5.4% |
| Q1 2019 | $12,416,000 | +87.0% | 1,501,272 | +10.6% | 11.52% | +43.0% |
| Q4 2018 | $6,639,000 | +1212.1% | 1,357,639 | +2548.6% | 8.05% | +1620.9% |
| Q3 2018 | $506,000 | -95.0% | 51,259 | -90.6% | 0.47% | -96.2% |
| Q4 2017 | $10,063,000 | -19.0% | 544,220 | 0.0% | 12.23% | -3.3% |
| Q3 2017 | $12,430,000 | – | 544,220 | – | 12.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 771,790 | $5,788,000 | 5.46% |
| RA Capital Management | 10,874,613 | $81,560,000 | 1.49% |
| Mesirow Financial Investment Management, Inc. | 36,445 | $273,000 | 1.17% |
| Samsara BioCapital, LLC | 451,162 | $3,384,000 | 0.94% |
| Parkman Healthcare Partners LLC | 310,053 | $2,325,000 | 0.62% |
| Orbimed Advisors | 5,465,030 | $40,988,000 | 0.52% |
| Eventide Asset Management | 3,450,000 | $25,875,000 | 0.51% |
| Vivo Capital, LLC | 786,883 | $5,902,000 | 0.34% |
| Ikarian Capital, LLC | 451,531 | $3,387,000 | 0.24% |
| Matisse Capital | 50,300 | $377,000 | 0.15% |